News

T. Daniel Logan's Promotion Marks a New Era for KKB Law Firm

T. Daniel Logan's Promotion Marks a New Era for KKB Law Firm

Kleinfeld Kaplan & Becker LLP Welcomes New Partner

In an exciting development for the legal community, Kleinfeld Kaplan & Becker LLP (KKB) has announced the election of T. Daniel "Dan" Logan as a partner in the firm. This change marks the beginning of a promising chapter for KKB as they continue to build a formidable team in the regulatory landscape. Mr. Logan officially steps into his new role effective January 1, 2025.

Professional Background and Expertise of Dan Logan

Mr. Logan has cultivated a robust practice specializing in regulatory compliance and advertising law, particularly in the food, cosmetic, drug, dietary supplement, and tobacco industries. His extensive knowledge, gained through years of dedicated service, positions him uniquely within the firm and the broader legal community.

Experience at the FDA

Prior to his tenure at KKB, Dan served as Associate Chief Counsel at the U.S. Food and Drug Administration (FDA). In this role, he provided legal guidance to subject matter experts and developed legal interpretations that fostered the FDA's regulatory objectives. His profound understanding of the intricacies of FDA regulations serves as a significant asset to KKB.

Contributions Beyond Legal Practice

While at the FDA, Mr. Logan was instrumental in various capacities including directing rulemakings and program development at the Center for Tobacco Products. His expertise also extends to overseeing investigations carried out by the Government Accountability Office and the Office of Inspector General of the Department of Health and Human Services.

Celebrating the Promotion's Impact

Will Woodlee, managing partner of KKB, expressed enthusiastic support for Mr. Logan's promotion. He remarked, "Dan’s broad range of skills, diverse experiences, and deep client relationships position him exceptionally well for making significant contributions to the partnership and the broader FDA bar for many years. His promotion will further strengthen our firm’s position among the most comprehensive FDA regulatory and advertising practices in the country.”

Educational Background

Mr. Logan earned his Juris Doctor (cum laude) from the Indiana University Maurer School of Law. He is an active member of the District of Columbia and Maryland bars, underscoring his commitment to legal excellence.

A Firm with a Legacy

Kleinfeld Kaplan & Becker LLP is not just any law firm; it has a rich history of over 60 years in navigating the complex legal waters of food and drug and advertising law. This Washington, DC-based boutique firm continuously addresses the myriad regulations imposed by the FDA on food, drugs and biologics, cosmetics, medical devices, dietary supplements, and tobacco products, among others. Their expertise extends to the realm of controlled substances, unfair trade practice investigations, and compliance issues related to Medicare and Medicaid.

Client-Centered Approach

The firm's client-centric philosophy is evident in the way they engage with consumer products and services regulations. Their deep understanding of the law enables them to offer tailored advice that aligns with their clients' unique needs.

Looking Ahead

KKB's future looks brighter with the addition of Dan Logan to the partnership. His wealth of experience and dedication will undoubtedly enhance their capability in providing quality legal services. As the firm evolves, they remain steadfast in their commitment to excellence, innovation, and client success.

Frequently Asked Questions

Who is T. Daniel Logan?

T. Daniel Logan is a newly elected partner at Kleinfeld Kaplan & Becker LLP known for his expertise in FDA regulatory compliance and advertising law.

When does Dan Logan officially become a partner?

Dan Logan's partnership at KKB takes effect on January 1, 2025.

What is KKB's area of focus?

KKB specializes in legal issues surrounding FDA regulations, including food, drug, and advertising law.

What notable roles did Logan have prior to joining KKB?

Before joining KKB, Logan was an Associate Chief Counsel at the FDA, advising on regulatory compliance and other legal matters.

How can clients contact Dan Logan?

Clients can reach Dan Logan at (202) 223-5120 or via email.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 3

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 2

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Into bluebird bio, Inc.’s Acquisition Proposal

Updated Category News Views 167

Understanding the Investigation into bluebird bio, Inc. Recent developments have captured the attention of shareholders and the financial community regarding bluebird bio, Inc. (NASDAQ: BLUE). Rowley Law PLLC has initiated an investigation exploring possible violations of securities law associated with the company’s proposed acquisition. This acquisition is a joint...

Continue Reading
Unwind in Paradise: The Seminyak Beach Resort's Escape

Updated Category News Views 105

Experience Tranquility at The Seminyak Beach Resort & Spa The Seminyak Beach Resort & Spa invites travelers everywhere to immerse themselves in the serene beauty of Bali with its new Seaside Escape package. This luxurious beachfront haven is celebrated for its genuine Balinese artistry and exceptional service, perfectly catering to those who seek a unique blend of...

Continue Reading
Lyte Fiber Launches Advanced Network to Enhance Connectivity

Updated Category News Views 468

Lyte Fiber Unveils Innovative Fiber Network Project Lyte Fiber, LLC is making significant strides in enhancing digital connectivity by initiating construction on its state-of-the-art multi-gigabit fiber network. This investment, amounting to over $11 million, aims to transform the digital landscape for homes and businesses. The company envisions an upgraded digital...

Continue Reading
ONE Gas Boosts Commercial Paper Program for Financial Flexibility

Updated Category News Views 67

ONE Gas Expands Its Commercial Paper Program ONE Gas, Inc. (NYSE: OGS), a prominent natural gas distribution company, has announced a significant increase in the limit of its commercial paper program. This update, disclosed through a recent SEC filing, raises the program's ceiling from $1.275 billion to $1.35 billion, reflecting the company's proactive approach in...

Continue Reading
Sogeclair's Voting Rights Update for Stakeholders in 2025

Updated Category News Views 133

Sogeclair's Insights on Voting Rights and Share Capital SOGECLAIR As a prominent business corporation with a capital of 3,204,901 Euros, Sogeclair is dedicated to maintaining transparency in its operations. The company is headquartered at 7 Avenue Albert Durand, BLAGNAC (France). If you need to reach out, the contact number is +33 (0)5.61.71.71.71 and more about the...

Continue Reading